NPPES file of Aug 9, 2026

Yoko Fukuda, M.D.

Hematology & Oncology Physician · Portsmouth, NH

Yoko Fukuda, M.D. is a hematology & oncology physician with a practice address in Portsmouth, New Hampshire, and NPI 1568622801, issued on Jun 10, 2008. Check the license (New Hampshire 16165, as entered in NPPES) on the New Hampshire Board of Medicine; the Medicare figures below come from public CMS files.

Record from CMS NPPES, file of Aug 9, 2026 · Medicare files 2024 · method · Verify with CMS →

NPPES recordNPPES file of Aug 9, 2026
1568622801
Name
Yoko Fukuda
Credential
M.D.
Primary taxonomy
Hematology & Oncology Physician 207RH0003X
License numbers
16165 NH
MD23455 ME
Self-reported in NPPES; status is on the state search
Practice location
155 Borthwick Ave Ste C, Portsmouth, NH 03801
Phone
(603) 828-0100
Enumerated
Jun 10, 2008
Record last updated
Apr 17, 2026
Fax
(603) 828-0111
Medicare enrollment
Enrolled (PECOS I20131210002087); accepts Medicare assignment
Telehealth
Offers telehealth (CMS)
Entity
Type 1 · individual
Public record from CMS NPPES (open it on the CMS NPI Registry). Enrollment, assignment, school and telehealth: CMS Doctors and Clinicians file, Aug 2026. A record is not a license: verify it with the state board.
Download card Updates feed

Also registered at 155 Borthwick Ave Ste C

A shared address usually means a shared clinic or building; it does not show who employs whom.

  1. Karen Kadish, NPNurse Practitioner1386633733
  2. Elizabeth Testa, LICSWClinical Social Worker1487288270
  3. Christine Wasilewski, MDHematology & Oncology Physician1376750562
  4. Lauren Zanetti, PA-CPhysician Assistant1578956538

Verify Yoko Fukuda in five checks

  1. 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
  2. 2LicenseActive license and public ordersNew Hampshire Board of Medicine
    Search for license 16165
    Check the board
  3. 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
  4. 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
  5. 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
Open the New Hampshire license search

PlainDoctor does not match the HHS-OIG exclusion list to individual records: most entries carry no NPI. Search the OIG exclusion list by name.

Is this page about you? You can ask us to correct, restrict or remove it: how.

43% more Medicare Part D claims than the average hematology & oncology physician in 2024

1,253 Medicare Part D claims for 205 beneficiaries, against an average of 877 among the 10,784 providers of this specialty who prescribed in Part D. Brand-name drugs were 31% of claims. 48 claims were for opioids.

  1. Yoko Fukuda1,253
  2. Specialty average877

Most prescribed

  1. Eliquis110 claims
  2. Letrozole82 claims
  3. Hydroxyurea74 claims
  4. Tamoxifen Citrate55 claims
  5. Potassium Chloride51 claims
  6. Anastrozole45 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

Industry payments in 2024: $401.85

25 payments; by number, the most common kind was food and beverage; the largest payer was Daiichi Sankyo Inc. The 8,560 providers of this specialty with any payment received $7,481.41 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.

  1. Yoko Fukuda$401.85
  2. Specialty average$7,481.41

Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.

Bills Medicare through one group practice

  1. Maine Center For Cancer Medicine And Blood Disorders PAPortsmouth, NH

Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).

Hematology & Oncology Physician providers in New Hampshire

There are 76 hematology & oncology physician records in New Hampshire.

Other hematology & oncology physician records in New Hampshire

  1. Elizabeth Bengtson, MDLebanon, NH1437269966
  2. Amy Bessnow, MDDover, NH1083766786
  3. Archana Bhargava, MDDover, NH1366457004
  4. Ananta Bhatt, M.D.Nashua, NH1295025435
  5. Eric Bonnem, MDManchester, NH1265426035
  6. Frederick Briccetti, MDConcord, NH1063406932
  7. Goran Broketa, MDManchester, NH1033153374
  8. Michael Buff, MDConcord, NH1699811547
  9. Wilhelmina Cabalona, MDPortsmouth, NH1265691927
  10. Charles Catcher, MDConcord, NH1114978749

Common questions

What is Yoko Fukuda, M.D.'s NPI number?

Yoko Fukuda, M.D.'s National Provider Identifier (NPI) is 1568622801, issued on Jun 10, 2008. An NPI identifies a provider in billing; it is not a license.

Where is Yoko Fukuda, M.D. located?

The NPPES record lists a practice address at 155 Borthwick Ave Ste C, Portsmouth, NH, 03801. Phone: (603) 828-0100. Providers update this record themselves, so call before visiting.

How can I verify Yoko Fukuda, M.D.'s license?

NPPES lists New Hampshire license number 16165, as entered by the provider. Search the New Hampshire Board of Medicine at https://www.oplc.nh.gov/board-medicine. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.

How much does Yoko Fukuda, M.D. prescribe under Medicare Part D?

In 2024, Yoko Fukuda, M.D. had 1,253 Medicare Part D claims for 205 beneficiaries; the average among hematology & oncology physician prescribers was 877. Part D covers Medicare prescriptions only.

Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.

Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.